Otsuka Pharmaceutical Co. Ltd.’s indirect US subsidiary Otsuka America Pharmaceutical Inc. has purchased the assets and intellectual property of distressed private US venture Proteus Digital Health, Inc. as the developer of ingestible and wearable sensor technology moves out of bankruptcy at a fire sale price.
The deal, confirmed in a brief statement from the major Japanese firm, throws a lifeline to Redwood City, CA-based Proteus,...
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?